An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder

Completed · Phase 2

Conditions studied: Depressive Disorder, Major

In brief

A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD)

Key facts

Study ID

NCT00057213

Run by

GlaxoSmithKline

People needed

367

Starts

2003-03-01

Expected to finish

2007-04-01

Last updated by the study team

2015-04-16

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Major Depressive Disorder (MDD)
• Duration of current depressive episode 12 weeks - 24 months
• Patients can read and write at a level sufficient to provide a signed consent
• If female, patients must be practicing an acceptable method of birth control

You may not qualify if…

• Patients have other psychiatric disorders that would affect patient's response to treatment
• Patients have not responded to two or more adequate courses of antidepressant therapy
• Patients cannot be currently abusing illicit drugs or alcohol
• Patients are not currently receiving psychotherapy
• Patients have received electroconvulsive therapy within 6 months prior to screening
• Patients are pregnant or lactating

Where it is running

• GSK Investigational Site — Peoria, Arizona, United States
• GSK Investigational Site — Scottsdale, Arizona, United States
• GSK Investigational Site — Garden Grove, California, United States
• GSK Investigational Site — Irvine, California, United States
• GSK Investigational Site — National City, California, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Winter Park, Florida, United States
• GSK Investigational Site — Springfield, Illinois, United States
• GSK Investigational Site — Terre Haute, Indiana, United States
• GSK Investigational Site — Florence, Kentucky, United States
• GSK Investigational Site — Brockton, Massachusetts, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Chapel Hill, North Carolina, United States
• GSK Investigational Site — Raleigh, North Carolina, United States
• GSK Investigational Site — Lyndhurst, Ohio, United States
• GSK Investigational Site — Eugene, Oregon, United States
• GSK Investigational Site — Philadelphia, Pennsylvania, United States
• GSK Investigational Site — Austin, Texas, United States
• GSK Investigational Site — Galveston, Texas, United States
• GSK Investigational Site — Lake Jackson, Texas, United States
• GSK Investigational Site — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.